nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—PDE5A—clitoris—adrenal gland cancer	0.391	0.515	CbGeAlD
Sildenafil—CYP2C19—urine—adrenal gland cancer	0.0389	0.0512	CbGeAlD
Sildenafil—PDE6G—adrenal gland—adrenal gland cancer	0.0357	0.047	CbGeAlD
Sildenafil—CYP2C9—urine—adrenal gland cancer	0.0301	0.0397	CbGeAlD
Sildenafil—CYP2E1—urine—adrenal gland cancer	0.0286	0.0376	CbGeAlD
Sildenafil—CYP3A4—urine—adrenal gland cancer	0.023	0.0303	CbGeAlD
Sildenafil—CYP2D6—urine—adrenal gland cancer	0.0226	0.0298	CbGeAlD
Sildenafil—ADORA2A—gonad—adrenal gland cancer	0.0178	0.0234	CbGeAlD
Sildenafil—PDE5A—gonad—adrenal gland cancer	0.0162	0.0213	CbGeAlD
Sildenafil—ADORA2A—adrenal gland—adrenal gland cancer	0.0155	0.0204	CbGeAlD
Sildenafil—ABCC10—adrenal cortex—adrenal gland cancer	0.0149	0.0197	CbGeAlD
Sildenafil—ABCC5—cardiac atrium—adrenal gland cancer	0.0148	0.0195	CbGeAlD
Sildenafil—ABCC5—pituitary gland—adrenal gland cancer	0.0144	0.019	CbGeAlD
Sildenafil—PDE5A—adrenal gland—adrenal gland cancer	0.0141	0.0186	CbGeAlD
Sildenafil—ABCC5—adrenal gland—adrenal gland cancer	0.0129	0.017	CbGeAlD
Sildenafil—ABCC10—gonad—adrenal gland cancer	0.0124	0.0163	CbGeAlD
Sildenafil—ABCC10—cardiac atrium—adrenal gland cancer	0.0123	0.0163	CbGeAlD
Sildenafil—ABCC10—pituitary gland—adrenal gland cancer	0.0121	0.0159	CbGeAlD
Sildenafil—ABCC10—adrenal gland—adrenal gland cancer	0.0108	0.0142	CbGeAlD
Sildenafil—ABCC4—adrenal gland—adrenal gland cancer	0.00894	0.0118	CbGeAlD
Sildenafil—CYP1A1—cardiac atrium—adrenal gland cancer	0.00686	0.00904	CbGeAlD
Sildenafil—CYP2E1—adrenal gland—adrenal gland cancer	0.00546	0.00719	CbGeAlD
Sildenafil—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00154	0.00641	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—TERT—adrenal gland cancer	0.00152	0.00631	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00151	0.00625	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—PRKACA—adrenal gland cancer	0.0015	0.00622	CbGpPWpGaD
Sildenafil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00147	0.0061	CbGpPWpGaD
Sildenafil—ABCC5—Carbohydrate metabolism—PRKACA—adrenal gland cancer	0.00142	0.00589	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00137	0.00568	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GNRHR—adrenal gland cancer	0.00136	0.00565	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.00135	0.00559	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00134	0.00557	CbGpPWpGaD
Sildenafil—CYP1A1—PPARA activates gene expression—MED12—adrenal gland cancer	0.00133	0.00551	CbGpPWpGaD
Sildenafil—ABCC4—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00132	0.0055	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00132	0.00549	CbGpPWpGaD
Sildenafil—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—adrenal gland cancer	0.0013	0.00539	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—CDC42—adrenal gland cancer	0.00127	0.00528	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00126	0.00525	CbGpPWpGaD
Sildenafil—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00126	0.00522	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—IGF2—adrenal gland cancer	0.00122	0.00508	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—GNAS—adrenal gland cancer	0.00121	0.00504	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00119	0.00493	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00115	0.00476	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00111	0.0046	CbGpPWpGaD
Sildenafil—ADORA2A—G alpha (s) signalling events—POMC—adrenal gland cancer	0.0011	0.00458	CbGpPWpGaD
Sildenafil—ABCC10—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00109	0.00452	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00108	0.00449	CbGpPWpGaD
Sildenafil—PDE6G—Disease—SPRY2—adrenal gland cancer	0.00106	0.00442	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—PRKACA—adrenal gland cancer	0.00103	0.0043	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00103	0.00428	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00102	0.00424	CbGpPWpGaD
Sildenafil—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00102	0.00423	CbGpPWpGaD
Sildenafil—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00102	0.00422	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000982	0.00408	CbGpPWpGaD
Sildenafil—PDE6G—Disease—MEN1—adrenal gland cancer	0.000974	0.00405	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SH3KBP1—adrenal gland cancer	0.000974	0.00405	CbGpPWpGaD
Sildenafil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000969	0.00402	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—SDHB—adrenal gland cancer	0.00096	0.00399	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000946	0.00393	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ZNRF3—adrenal gland cancer	0.000916	0.00381	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000912	0.00379	CbGpPWpGaD
Sildenafil—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00091	0.00378	CbGpPWpGaD
Sildenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000908	0.00377	CbGpPWpGaD
Sildenafil—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—adrenal gland cancer	0.000894	0.00372	CbGpPWpGaD
Sildenafil—PDE6G—Signaling by Wnt—CTNNB1—adrenal gland cancer	0.00087	0.00361	CbGpPWpGaD
Sildenafil—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000858	0.00356	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000846	0.00351	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GNRH1—adrenal gland cancer	0.000814	0.00338	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.000797	0.00331	CbGpPWpGaD
Sildenafil—CYP1A1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000791	0.00329	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SPRY2—adrenal gland cancer	0.000745	0.00309	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PRKACA—adrenal gland cancer	0.000744	0.00309	CbGpPWpGaD
Sildenafil—CYP2E1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000737	0.00306	CbGpPWpGaD
Sildenafil—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000736	0.00306	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TSHR—adrenal gland cancer	0.000726	0.00301	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000725	0.00301	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000718	0.00298	CbGpPWpGaD
Sildenafil—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000702	0.00292	CbGpPWpGaD
Sildenafil—CYP1A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000695	0.00289	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MEN1—adrenal gland cancer	0.000682	0.00283	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—SPARC—adrenal gland cancer	0.000681	0.00283	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000648	0.00269	CbGpPWpGaD
Sildenafil—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000648	0.00269	CbGpPWpGaD
Sildenafil—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000645	0.00268	CbGpPWpGaD
Sildenafil—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00064	0.00266	CbGpPWpGaD
Sildenafil—ABCC4—Ectoderm Differentiation—CTNNB1—adrenal gland cancer	0.000633	0.00263	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CDC42—adrenal gland cancer	0.000631	0.00262	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—RRM1—adrenal gland cancer	0.000618	0.00257	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—SDHD—adrenal gland cancer	0.000618	0.00257	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—BAD—adrenal gland cancer	0.000613	0.00255	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.0006	0.00249	CbGpPWpGaD
Sildenafil—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.0006	0.00249	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000594	0.00247	CbGpPWpGaD
Sildenafil—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00059	0.00245	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000588	0.00244	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000582	0.00242	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.00058	0.00241	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000577	0.0024	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PRKACA—adrenal gland cancer	0.000575	0.00239	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SPRY2—adrenal gland cancer	0.000574	0.00239	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000571	0.00237	CbGpPWpGaD
Sildenafil—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000569	0.00236	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—BRAF—adrenal gland cancer	0.000558	0.00232	CbGpPWpGaD
Sildenafil—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.000541	0.00225	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000539	0.00224	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MEN1—adrenal gland cancer	0.000526	0.00219	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000525	0.00218	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000524	0.00218	CbGpPWpGaD
Sildenafil—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000523	0.00217	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PRKACA—adrenal gland cancer	0.000521	0.00216	CbGpPWpGaD
Sildenafil—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000519	0.00215	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000507	0.00211	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TERT—adrenal gland cancer	0.000506	0.0021	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000498	0.00207	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—CDC42—adrenal gland cancer	0.000488	0.00203	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.000483	0.00201	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—IGF2—adrenal gland cancer	0.00047	0.00195	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—GNAS—adrenal gland cancer	0.000466	0.00194	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—MED12—adrenal gland cancer	0.000461	0.00192	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CDC42—adrenal gland cancer	0.000442	0.00184	CbGpPWpGaD
Sildenafil—PDE6G—Disease—BAD—adrenal gland cancer	0.00044	0.00183	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IGF2—adrenal gland cancer	0.000426	0.00177	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—GNAS—adrenal gland cancer	0.000422	0.00175	CbGpPWpGaD
Sildenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000422	0.00175	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000415	0.00173	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IGF1R—adrenal gland cancer	0.000412	0.00171	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000403	0.00168	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PRKACA—adrenal gland cancer	0.000402	0.00167	CbGpPWpGaD
Sildenafil—PDE6G—Disease—BRAF—adrenal gland cancer	0.000401	0.00166	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.0004	0.00166	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000396	0.00164	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	0.000392	0.00163	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.000391	0.00162	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—adrenal gland cancer	0.000388	0.00161	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000376	0.00156	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—POMC—adrenal gland cancer	0.000369	0.00153	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000356	0.00148	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—adrenal gland cancer	0.000356	0.00148	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TERT—adrenal gland cancer	0.000354	0.00147	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000351	0.00146	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SDHB—adrenal gland cancer	0.00035	0.00145	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000349	0.00145	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000348	0.00144	CbGpPWpGaD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000342	0.00142	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CDC42—adrenal gland cancer	0.000341	0.00142	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PRKACA—adrenal gland cancer	0.000336	0.0014	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000336	0.0014	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SDHB—adrenal gland cancer	0.00033	0.00137	CbGpPWpGaD
Sildenafil—PDE6G—Disease—PTGS2—adrenal gland cancer	0.000324	0.00134	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—EGFR—adrenal gland cancer	0.000319	0.00133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000319	0.00133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000318	0.00132	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.000312	0.00129	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.000312	0.00129	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.00031	0.00129	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—BAD—adrenal gland cancer	0.000308	0.00128	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000305	0.00127	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000302	0.00126	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000291	0.00121	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000291	0.00121	CbGpPWpGaD
Sildenafil—PDE6G—Disease—CTNNB1—adrenal gland cancer	0.00029	0.0012	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—POMC—adrenal gland cancer	0.000284	0.00118	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—BRAF—adrenal gland cancer	0.000281	0.00117	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000278	0.00115	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000276	0.00114	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TERT—adrenal gland cancer	0.000273	0.00114	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GNAS—adrenal gland cancer	0.000273	0.00113	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.00027	0.00112	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ABCB1—adrenal gland cancer	0.000267	0.00111	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000266	0.0011	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00026	0.00108	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000248	0.00103	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000246	0.00102	CbGpPWpGaD
Sildenafil—ABCC5—Disease—BAD—adrenal gland cancer	0.000238	0.000988	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.000232	0.000965	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EGFR—adrenal gland cancer	0.000229	0.000953	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000226	0.00094	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SDHD—adrenal gland cancer	0.000226	0.000938	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—RRM1—adrenal gland cancer	0.000226	0.000938	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000225	0.000936	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000225	0.000936	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000222	0.000924	CbGpPWpGaD
Sildenafil—ABCC5—Disease—BRAF—adrenal gland cancer	0.000216	0.000899	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—RRM1—adrenal gland cancer	0.000213	0.000884	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SDHD—adrenal gland cancer	0.000213	0.000884	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000213	0.000883	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000205	0.000853	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000203	0.000843	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000194	0.000805	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000189	0.000783	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—POMC—adrenal gland cancer	0.000184	0.000763	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000182	0.000755	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000182	0.000755	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.00018	0.000749	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000176	0.00073	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—adrenal gland cancer	0.000175	0.000726	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000174	0.000723	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000174	0.000723	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.000169	0.000704	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—MED12—adrenal gland cancer	0.000168	0.000699	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.000168	0.000698	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000162	0.000675	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—adrenal gland cancer	0.000161	0.000668	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.00016	0.000665	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.00016	0.000665	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000159	0.00066	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000159	0.00066	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—MED12—adrenal gland cancer	0.000159	0.000659	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CTNNB1—adrenal gland cancer	0.000156	0.00065	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000151	0.000628	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—adrenal gland cancer	0.000149	0.000619	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—adrenal gland cancer	0.000146	0.000608	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000142	0.000589	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.000137	0.000571	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—adrenal gland cancer	0.000135	0.000561	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000135	0.00056	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000132	0.000547	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.00013	0.000539	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—adrenal gland cancer	0.000124	0.000515	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	0.000123	0.00051	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000122	0.000509	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000121	0.000504	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.00012	0.000498	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000119	0.000496	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000118	0.000492	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000116	0.000482	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000116	0.000482	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PRKACA—adrenal gland cancer	0.000116	0.000481	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000113	0.00047	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000106	0.00044	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000105	0.000435	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000105	0.000435	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GNAS—adrenal gland cancer	9.95e-05	0.000413	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GNAS—adrenal gland cancer	9.93e-05	0.000412	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	9.76e-05	0.000406	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	9.74e-05	0.000405	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	9.47e-05	0.000393	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GNAS—adrenal gland cancer	9.38e-05	0.00039	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.26e-05	0.000385	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—POMC—adrenal gland cancer	9.25e-05	0.000384	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ABCB1—adrenal gland cancer	9.2e-05	0.000382	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	8.71e-05	0.000362	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	8.66e-05	0.00036	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	8.63e-05	0.000359	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	8.44e-05	0.000351	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—MED12—adrenal gland cancer	7.81e-05	0.000324	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GNAS—adrenal gland cancer	7.68e-05	0.000319	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	7.53e-05	0.000313	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	7.38e-05	0.000306	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GNAS—adrenal gland cancer	7.06e-05	0.000293	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GNAS—adrenal gland cancer	7e-05	0.000291	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	6.93e-05	0.000288	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	6.87e-05	0.000285	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—adrenal gland cancer	6.86e-05	0.000285	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—POMC—adrenal gland cancer	6.7e-05	0.000278	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—POMC—adrenal gland cancer	6.68e-05	0.000278	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—POMC—adrenal gland cancer	6.32e-05	0.000262	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—adrenal gland cancer	5.76e-05	0.000239	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.69e-05	0.000237	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	5.34e-05	0.000222	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	5.33e-05	0.000221	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—POMC—adrenal gland cancer	5.17e-05	0.000215	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—adrenal gland cancer	5.04e-05	0.000209	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—POMC—adrenal gland cancer	4.75e-05	0.000197	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—POMC—adrenal gland cancer	4.71e-05	0.000196	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.62e-05	0.000192	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.53e-05	0.000188	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	4.12e-05	0.000171	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	3.79e-05	0.000158	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	3.76e-05	0.000156	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—POMC—adrenal gland cancer	3.11e-05	0.000129	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.48e-05	0.000103	CbGpPWpGaD
